Task: Answer the multiple-choice question.
Question: Which drug exhibits a -73.468% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. Brc1csc(C=Nc2ccc3c(c2)OCCOCCOCCOCCO3)c1
b. Cc1occc1-c1nnc(SCC(N)=O)o1
Answer: a. Brc1csc(C=Nc2ccc3c(c2)OCCOCCOCCOCCO3)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Brc1csc(C=Nc2ccc3c(c2)OCCOCCOCCOCCO3)c1
Brc1csc(C=Nc2ccc3c(c2)OCCOCCOCCOCCO3)c1
1-(4-bromothiophen-2-yl)-N-(2,5,8,11,14-pentaoxabicyclo[13.4.0]nonadeca-1(15),16,18-trien-17-yl)methanimine